id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-E-1946-0003,FDA,FDA-2019-E-1946,Letter from FDA to U.S. Patent and Trademark Office,Other,Letter(s),2019-06-21T04:00:00Z,2019,6,2019-06-21T04:00:00Z,,2019-06-21T14:24:59Z,,0,0,0900006483d30819
FDA-2019-E-1946-0002,FDA,FDA-2019-E-1946,"Patent Extension Application from Arent Fox LLP (on behalf of ZS Pharma, Inc.)",Other,Application,2019-04-23T04:00:00Z,2019,4,2019-04-23T04:00:00Z,,2019-04-23T19:52:04Z,,0,0,0900006483be6d39
FDA-2019-E-1946-0001,FDA,FDA-2019-E-1946,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2019-04-23T04:00:00Z,2019,4,2019-04-23T04:00:00Z,,2019-04-23T19:48:33Z,,0,0,0900006483be68da